We are monitoring the impact of COVID-19 on Latin America OTC Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 465
Share on
Share on

Latin America Over the Counter Drugs Market Research Report - Segmented By Product Type, Formulation Type, Distribution Channels & Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 465
Pages: 145

Latin America OTC Drugs Market Size (2021 to 2026)

The Latin America size over the counter drugs market was estimated at USD 11.45 Million in 2021. It is projected to reach USD 17.33 Million by 2026, growing at a CAGR of 8.64% between 2021 to 2026.

The growth of the Latin American market is primarily driven by the high penetration, product innovation in integrating markets, a favorable regulatory framework, and pharmaceutical companies' trend to move from prescription to OTC drugs. The over-the-counter (OTC) pharmaceutical market is likely to record the highest growth rates in emerging markets like Latin America and Southeast Asia in the coming years. This is attributed to the growth of the middle class and the increase in the population's disposable income in these regions, maybe due to rapid population growth and the increasing availability of OTC drugs. Accessibility of supermarkets and emerging retail channels contributes to the growth of the OTC drugs market in Latin America.

In Latin America Over the Counter Drugs Market, the western lifestyle adoption, over-the-counter product promotion, and marketing programs increased healthcare spending, and the growing elderly population is supposed to promote development in this business during the forecast period.

In Latin America OTC Drugs Market, weight loss and diet products are considered to have the highest CAGR of 8.10% during the forecast period. This is mainly due to increased public awareness of health and increased consumption of junk food, which has led to an increase in lifestyle-related diseases. VMS and over-the-counter drug weight loss contribute most to the overall market. Almost a quarter of the market belongs to this kind of competition. This large share was attributed to the large customer base of various products in this category. Unlike other natural conditions, VMS and weight loss conditions are not bothersome. OTC products, in these cases, are more prophylactic than therapeutic or healing products. This is why the number of customers is relatively high compared to other metrics. A large customer base is generating high demand and making high profits. Due to the growing unhealthy population, VMS products are top-rated in developed countries, which is now found in Latin American regions.

The increased likelihood of substance abuse due to lack of awareness can hinder Latin America Over the Counter Drugs Market, resulting in underdevelopment during the projection period.

The competition among existing market players, substance abuse, misdiagnosis, and lack of awareness of developing and rural populations is a challenge to this industry.

This research report on the Latin America OTC Drugs Market has been segmented and sub-segmented into the following categories:

By Product Type: 

  • Analgesics
  • Cough, Cold, and Flu Products
  • Vitamins and Minerals
  • Dermatological Products
  • Gastrointestinal Products
  • Ophthalmic Products
  • Sleep Aid Products
  • Weight Loss/Diet Products
  • Others

By Formulation Type:

  • Tablets
  • Liquids
  • Ointments
  • Spray                             

By Distribution Channels: 

  • Pharmacies
  • Supermarkets/Hypermarkets
  • Convenience store
  • Others (online drug store)                             

By Country: 

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Regionally, in terms of revenue, Brazil is the prominent market for over-the-counter drugs, followed by Argentina. The Latin American market is foreseen to achieve strong growth during the forecast period. This strong growth is credited to the rise of the healthcare industry and increased government investment in the medical sector development. OTC markets in countries such as Brazil are supposed to grow at a high rate during the outlook period due to increasing awareness of these drugs' use in treating minor health problems.

Prominent companies leading in the Latin America over counter Drugs Market profiled in the report are GlaxoSmithKline, Johnson and Johnson, Novartis, Bayer, Pfizer, Sanofi Takeda.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product Type                             

                                5.1.1 Analgesics

                                5.1.2 Cough, Cold and Flu Products         

                                5.1.3 Vitamins and Minerals       

                                5.1.4 Dermatological Products   

                                5.1.5 Gastrointestinal Products 

                                5.1.6 Ophthalmic Products          

                                5.1.7 Sleep Aid Products              

                                5.1.8 Weight Loss/Diet Products               

                                5.1.9 Others      

                5.2 By Formulation Type                              

                                5.2.1 Tablets      

                                5.2.2 Liquids      

                                5.2.3 Ointments               

                                5.2.4 Sprays       

                5.3 Distribution Channels                             

                                5.3.1 Pharmacies             

                                5.3.2 Supermarkets/Hypermarkets         

                                5.3.3 Convenience stores            

                                5.3.4 Others (Online Drug Stores)            

6. Geographical Analysis                                              

                6.1 Introduction                               

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Argentina                    

                6.5 Rest of Latin America                             

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 GlaxoSmithKline                       

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Johnson and Johnson                            

                8.3 Novartis                       

                8.4 Bayer                            

                8.5 Pfizer                            

                8.6 Boehringer Ingelheim                            

                8.7 Sanofi                           

                8.8 Takeda                         

                8.9 PGT Healthcare                         

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Over the Counter (OTC) Drugs Market, By Region, From 2021 to 2026 (USD Million)
  2. Latin America Over the Counter (OTC) Drugs Market, By Product Type, From 2021 to 2026 (USD Million)
  3. Latin America Analgesics Market, By Region, From 2021 to 2026 (USD Million)
  4. Latin America Cough Market, By Region, From 2021 to 2026 (USD Million)
  5. Latin America Cold and Flu Products Market, By Region, From 2021 to 2026 (USD Million)
  6. Latin America Dermatological Products Market, By Region, From 2021 to 2026 (USD Million)
  7. Latin America Gastrointestinal Products Market, By Region, From 2021 to 2026 (USD Million)
  8. Latin America Vitamins Market, By Region, From 2021 to 2026 (USD Million)
  9. Latin America Minerals Market, By Region, From 2021 to 2026 (USD Million)
  10. Latin America Weight Loss Products Market, By Region, From 2021 to 2026 (USD Million)
  11. Latin America Sleep Aids Market, By Region, From 2021 to 2026 (USD Million)
  12. Latin America Ophthalmic Products Market, By Region, From 2021 to 2026 (USD Million)
  13. Latin America Smoking Cession Aids Market, By Region, From 2021 to 2026 (USD Million)
  14. Latin America Other Products Market, By Region, From 2021 to 2026 (USD Million)
  15. Brazil Over the Counter (OTC) Drugs Market, By Product Type, From 2021 to 2026 (USD Million)
  16. Argentina Over the Counter (OTC) Drugs Market, By Product Type, From 2021 to 2026 (USD Million)
  17. Mexico Over the Counter (OTC) Drugs Market, By Product Type, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample